Methods and compositions related to targeting monoacylglycerol lipase
This invention provides compounds that selectively inhibit monoacylglycerol lipase (MAGL). The invention also provides methods of using the MAGL selective inhibitors to stimulate 2-Arachidonoylglycerol (2-AG) mediated endocannabinoid signaling in vivo, and to treat conditions that are associated with or linked to endocannabinoid signaling. The invention additionally provides methods of treating cancer or inhibiting tumor growth by targeting MAGL with MAGL specific inhibitors. The invention further provides methods of screening for MAGL inhibitors with improved biochemical and pharmaceutical properties.
The Scripps Research Institute
A A A A C C A A A A A C A A A A
A61P A61P A61K A61P C12N C12N A61P A61P A61P A61P A61P C12N A61P A61P A61K A61P
inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional
Jonathan Z. Daniel K. Benjamin F. Weiwei
Long Nomura Cravatt Li